Knowles Corporation (KN) - Q1 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2025. Knowles Corporation is a manufacturer of specialty electronic components serving medtech, defense, and industrial markets. The company recently completed the sale of its Consumer MEMS Microphones (CMM) segment to Syntiant Corp. on December 27, 2024. Consequently, CMM results are classified as discontinued operations for all periods presented. The company operates through two reportable segments: Precision Devices (PD) and MedTech & Specialty Audio (MSA).
Key Financial Metrics
| Metric (in millions) | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenues | $132.2 | $133.3 |
| Gross Profit | $53.3 | $53.2 |
| Gross Margin | 40.3% | 39.9% |
| Operating Earnings | $4.0 | $5.0 |
| Net (Loss) Earnings | $(2.0) | $2.5 |
| Diluted EPS | $(0.02) | $0.03 |
| Cash and Equivalents | $101.9 | $122.1 |
| Total Debt | $188.8 | $202.5 |
| Operating Cash Flow | $1.3 | $17.3 |
Non-GAAP Highlights: Adjusted EBIT was $21.7 million (16.4% margin) compared to $23.3 million (17.5% margin) in Q1 2024. Non-GAAP diluted EPS was $0.18 for both periods.
Material Changes vs. Prior Period
- Revenue: Decreased 0.8% to $132.2 million. Precision Devices revenue declined $1.8 million due to lower industrial and defense demand, partially offset by higher medtech demand. MedTech & Specialty Audio revenue increased $0.7 million, driven by higher metal can shipments to Syntiant.
- Profitability: GAAP Net Loss was $2.0 million, compared to Net Earnings of $2.5 million in Q1 2024. The swing was primarily driven by a $1.6 million loss from discontinued operations (vs. $3.5 million gain in 2024) due to working capital adjustments on the CMM sale.
- Expenses: Restructuring charges increased to $2.9 million (vs. $2.5 million in 2024) to rightsize operations post-CMM sale. Stock-based compensation expense rose significantly to $10.2 million (vs. $5.1 million in 2024), partly due to a correction of a historical accounting error regarding retirement-eligible employees.
- Interest: Net interest expense decreased to $2.7 million (vs. $4.4 million in 2024) due to lower revolver balances and reduced imputed interest on the Seller Note.
Guidance, Outlook, and Risks
- Outlook: Management notes that industrial market inventory levels are normalizing, leading to increased distribution orders and backlog in the capacitor product line. Capital expenditures for 2025 are expected to be 4% to 6% of revenues.
- Tariffs: The company is monitoring new U.S. tariffs announced in April 2025. While preliminary analysis suggests no material impact, the company is implementing pricing actions and cost controls to mitigate risks.
- Share Repurchases: The Board authorized an additional $150 million in repurchase capacity in February 2025. The company repurchased $5.0 million of stock in Q1 2025, with $189.0 million remaining under the program.
- Risks: Key risks include global economic instability, supply chain disruptions, intellectual property litigation, and the ability to realize synergies from the CMM divestiture and CD acquisition.
Investor Verification Checklist
- Discontinued Operations Impact: Verify the $1.6 million loss from discontinued operations related to working capital adjustments on the CMM sale and its effect on the bottom line.
- Stock-Based Compensation Correction: Review the $1.1 million expense correction related to historical stock-based compensation errors and its impact on the effective tax rate (150% GAAP ETR).
- Segment Mix: Analyze the shift in revenue mix, specifically the lower-margin metal can sales to Syntiant impacting MSA gross margins.
- Liquidity Position: Confirm the reduction in cash from $130.1 million to $101.9 million and the $15.0 million repayment on the revolving credit facility.
- Debt Covenants: Verify continued compliance with the Interest Coverage Ratio (3.00:1) and Total Net Leverage Ratio (3.75:1) covenants.